Loading…
Quanterix Corporation is projected to rise to $3.86 by 2027, a +11% move from its current price of $3.48. QTRX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $3.34 | $3.48 | $3.63 | +0.07% |
| Aug 5 | $3.29 | $3.48 | $3.69 | +0.13% |
| Aug 6 | $3.25 | $3.49 | $3.74 | +0.20% |
| Aug 7 | $3.22 | $3.49 | $3.78 | +0.27% |
| Aug 8 | $3.19 | $3.49 | $3.82 | +0.33% |
| Aug 9 | $3.17 | $3.49 | $3.86 | +0.40% |
| Aug 10 | $3.14 | $3.50 | $3.89 | +0.47% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.14 | $3.50 | $3.89 | +0.47% |
| Week 2 | $3.02 | $3.51 | $4.08 | +0.93% |
| Week 3 | $2.93 | $3.53 | $4.24 | +1.40% |
| Week 4 | $2.87 | $3.55 | $4.39 | +1.88% |
| Week 5 | $2.81 | $3.56 | $4.52 | +2.35% |
| Week 6 | $2.76 | $3.58 | $4.64 | +2.83% |
| Week 7 | $2.71 | $3.60 | $4.76 | +3.31% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Quanterix Corporation is a life sciences company operating in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers the HD-X instrument, a protein detection platform; and the SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays.
The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, the company offers contract research and clinical laboratory testing services, including research and clinical trial testing, and lucent diagnostic services. The company primarily operates in the areas of neurology, oncology and immunology, and inflammation.
It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and sales force and distributors.
The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Quanterix Corporation (QTRX) is a healthcare company currently priced at $3.38, with a market capitalization of $159.22M and a rank of 3947.
The stock faces a mixed price outlook in the near term, with 2026 and 2027 labeled NEUTRAL in the forecast, followed by a bullish trajectory from 2028 through 2050 as prices move higher and the max/min/avg forecasts rise over time.
From 2026 to 2050, the forecast shows the average price progressing from $3.38 in 2026 to higher levels, with a max forecast climbing to $37.47 by 2050. Notable year-by-year averages include $5.21 in 2030, $7.01 by 2040, and $16.94 by 2050, with corresponding max values up to $8.37 (2030), $13.80 (2040), and $37.47 (2050). The implied ROI grows from 0% in 2026 to 54% in 2030, 107.5% by 2040, and 401.1% by 2050, reflecting a bullish long-term outlook.
A major floor 30.3% below — a decisive break under it would weaken the trend.
The nearest floor, 7.5% below — buyers have tended to step in here.
The nearest ceiling, 30.5% above — a clean break opens room to run.
A major ceiling 45.6% above — clearing it would confirm fresh momentum.
Key QTRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of QTRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.51 | Sell | $3.53 | Sell |
| MA 10 | $3.68 | Sell | $3.64 | Sell |
| MA 20 | $3.84 | Sell | $3.73 | Sell |
| MA 50 | $3.56 | Sell | $3.69 | Sell |
| MA 100 | $3.55 | Sell | $3.93 | Sell |
| MA 200 | $4.94 | Sell | $4.67 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.87 | Neutral |
| Stoch RSI (14) | 15.79 | Buy |
| CCI (20) | -130.57 | Sell |
| Williams %R (14) | -88.37 | Info |
| MACD (12,26,9) | -0.08 | Sell |
| ROC (12) | -17.92 | Sell |
| Bollinger %B (20,2) | 0.12 | Neutral |
| Stochastic %K (14) | 11.63 | Buy |
| TRIX (15) | 0.19 | Buy |
| Awesome (5,34) | -0.27 | Sell |
| Ultimate (7,14,28) | 33.90 | Neutral |
| Momentum (10) | -0.38 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 3.37 | Buy |
| ADX (14) | 13.91 | Neutral |
| ATR (14) | 0.13 | Info |
The 30-day technical picture is BEARISH, with RSI14 at 40. The price is trading below the SMA50 of $3.52 and below the SMA200 of $4.96, suggesting near-term weakness. Support is at $2.88 and resistance at $4.54, with a 30-day price range of $2.57 to $4.45.
The stock exhibits high volatility, with annualized volatility at 80%, underscoring the swing risk in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.51 | $3.48 | $4.72 | 0% | Neutral | |
| $2.95 | $3.86 | $5.42 | +11% | Neutral | |
| $3.50 | $4.79 | $7.08 | +38% | Bullish | |
| $3.79 | $5.37 | $8.27 | +54% | Bullish | |
| $3.81 | $5.58 | $8.88 | +60% | Bullish | |
| $3.85 | $5.82 | $9.53 | +67% | Bullish | |
| $3.29 | $5.12 | $8.60 | +47% | Bullish | |
| $3.36 | $5.36 | $9.22 | +54% | Bullish | |
| $4.05 | $6.64 | $11.66 | +91% | Bullish | |
| $4.35 | $7.31 | $13.08 | +110% | Bullish | |
| $4.33 | $8.18 | $15.86 | +135% | Bullish | |
| $8.83 | $19.62 | $42.63 | +464% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.51 | $3.48 | $4.08 | +0.00% |
| September 2026 | $2.87 | $3.44 | $4.28 | -1.07% |
| October 2026 | $3.05 | $3.70 | $4.66 | +7.38% |
| November 2026 | $3.04 | $3.71 | $4.74 | +0.44% |
| December 2026 | $2.97 | $3.66 | $4.72 | -1.56% |
Click any year to see its month-by-month QTRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, QTRX could reach as high as $4.72, with a base case around $3.48 and support toward $2.51 — roughly 0% from $3.48. Price action looks broadly range-bound.
Expect QTRX to range from $2.95 to $5.42 through 2027. The $3.86 average target implies a +11% move from current prices. That is up +11% on the projected 2026 average. A consolidation phase looks the most probable path here.
The QTRX price prediction for 2028 points to an average of $4.79 (low $3.50, high $7.08) — a potential gain of +38% on today's $3.48. Momentum favours further upside here.
In 2029, QTRX is projected to trade between $3.79 and $8.27, averaging $5.37 — a potential gain of +54% from today's $3.48. That is up +12% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Quanterix Corporation's 2030 outlook centres on $5.58, within a $3.81 to $8.88 range. That is up +4% on the projected 2029 average. That marks a +60% change versus current levels. Momentum favours further upside here.
By 2031, QTRX could reach as high as $9.53, with a base case around $5.82 and support toward $3.85 — roughly +67% from $3.48. Buyers look set to stay in control over this stretch.
Expect QTRX to range from $3.29 to $8.60 through 2032. The $5.12 average target implies a +47% move from current prices. That is -12% versus the projected 2031 average. Momentum favours further upside here.
The QTRX price prediction for 2033 points to an average of $5.36 (low $3.36, high $9.22) — a potential gain of +54% on today's $3.48. Buyers look set to stay in control over this stretch.
In 2034, QTRX is projected to trade between $4.05 and $11.66, averaging $6.64 — a potential gain of +91% from today's $3.48. That is up +24% on the projected 2033 average. Momentum favours further upside here.
Quanterix Corporation's 2035 outlook centres on $7.31, within a $4.35 to $13.08 range. That is up +10% on the projected 2034 average. That marks a +110% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, QTRX could reach as high as $15.86, with a base case around $8.18 and support toward $4.33 — roughly +135% from $3.48. Momentum favours further upside here.
Expect QTRX to range from $8.83 to $42.63 through 2050. The $19.62 average target implies a +464% move from current prices. That is up +140% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in QTRX today (≈ 287.356322 QTRX) could be worth
$5,636.55
+$4,636.55 (+464%) by 2050 · US Dollar
Based on the average projected QTRX price of $19.62 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in QTRXwould be worth at today's price.
$1,000 invested in QTRX on Jul 31, 2025 (≈ 168.350167 QTRX) would be worth
$585.86
-$414.14 (-41.4%) today · 0.59× · US Dollar
Based on a QTRX entry price of $5.94 vs. today's $3.48.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.67 | $948.23 | -5.2% |
| 1 month ago | $4.34 | $801.84 | -19.8% |
| 3 months ago | $3.4 | $1,023.53 | +2.4% |
| 6 months ago | $6.5 | $535.38 | -46.5% |
| 1 year ago | $5.94 | $585.86 | -41.4% |
| All time (5.0y) ago | $55.14 | $63.11 | -93.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our QTRX forecast.
Our base-case forecast reaches $7.00 around 2035.
Implied market cap at $7.00: $329.74M
The multi-year forecast shows a bullish trajectory beginning in 2028 and continuing through 2050. In 2028 the average forecast price is $4.39, rising to $5.02 in 2029 and $5.21 in 2030, with 2031 at $5.31. The outlook then evolves through 2032 ($4.65), 2033 ($4.82), 2034 ($5.81), and 2035 ($6.41), before advancing to 2040 ($7.01) and ultimately to 2050 ($16.94).
ROI progresses from 0% in 2026 to 7.3% in 2027, then climbs to 29.9% in 2028, 48.6% in 2029, 54% in 2030, 57.1% in 2031, 37.6% in 2032, 42.7% in 2033, 71.9% in 2034, 89.5% in 2035, 107.5% in 2040, and 401.1% in 2050, with a bullish sentiment indicated from 2028 onward.
These are estimates and not guarantees; actual results depend on market conditions and company performance. The forecast depicts potential upside but carries inherent uncertainty.
Tap a question to reveal the answer.
2030 avg $5.21, min $3.51, max $8.37; ROI 54%.
The forecast shows bullish sentiment from 2028 onward with rising averages and ROI up to 401.1% by 2050; these are estimates, not guarantees.
Yes, the forecast shows max prices above $10 in 2035 ($11.62) and 2040 ($13.80).
Avg $7.01, min $3.62, max $13.80; ROI 107.5%.
Avg $16.94, min $7.62, max $37.47; ROI 401.1%.
Quanterix Corporation Community Discussion
0Share your Quanterix Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.